StonvexLoading…
StonvexStonvexStonvexCore line items from MMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $171.47M | $755.16M | $511.21M | $317.31M |
Operating Income | $-5.78M | $-13.71M | $-29.13M | $-26.76M |
Net Income | $-3.10M | $-1.91M | $-15.22M | $-15.46M |
EPS (Diluted) | $-0.08 | $-0.05 | $-0.39 | $-0.40 |
Total Assets | $754.96M | $827.18M | $812.49M | $792.21M |
Total Liabilities | $185.91M | $224.08M | $210.25M | $184.43M |
Cash & Equivalents | $136.51M | $161.92M | $117.36M | $85.95M |
Free Cash Flow OCF − CapEx | $-30.55M | $58.78M | $14.91M | $-35.05M |
Shares Outstanding | 37.82M | 38.42M | 39.06M | 39.00M |